Abstract

Butea monosperma is a renowned therapeutic plant, a medium size deciduous tree broadly dispersed in India, Bangladesh, Cambodia, Myanmar, China South-Central, Nepal, Laos, Sri Lanka, China Southeast, Pakistan, and Vietnam. Butea monosperma is being used in customary medication preparation from the pre historic period. It is acknowledged as the forest’s flame and is often branded as Dhak or Palash. It is described in Upanishads, Susruta Samhita, Vedas, Ashtanga Sangraha, Astanga Hridaya, and Charka Samhita. It belongs to the family of Fabaceae, which has an extensive range of vigorous principles, and it has phytoconstituents such as glycosides, flavonoids, etc.This revisional analysis is focused on the pharmacological actions, mainly shown by seeds, flowers, fruits, barks,leaves, etc., like anti-diabetic, anthelmintic, hepatoprotective, anti-stress, anti-implantation, anti-convulsant, wound healing, giardiasis, anti-oxidant, anti-dopaminergic, anti-microbial, sunscreen, anti-diarrheal, free radical scavenging, anti-filarial, anti-fungal, nephroprotective, protease inhibitor, osteogenic, hemagglutinating, anti-ulcer, giardiasis, anti-asthmatic, anti-inflammatory, anti-fertility and anti-cancer activity. GC-MS analysis of Butea monospermashows the attendance of important compounds which is volatile and HPLC analysis for non-volatile, which supplies light to its medicinal properties. These therapeutic chattels may provide impending active principles with advanced usefulness and the leastafter-effects as equated to accessible artificial drugs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.